Form 4: iRhythm Technologies CEO Blackford Reports Stock Transactions

Quentin S. Blackford, CEO of iRhythm Technologies, reports acquisition and disposal of company stock related to vesting of performance-based restricted stock units (RSUs) and tax obligations.

Summary

• Quentin S. Blackford, the President and CEO of iRhythm Technologies, reported transactions involving the company's common stock.
• On February 25, 2025, Blackford acquired 40,610 shares of common stock at $0, related to performance-based restricted stock units (RSUs) granted on February 16, 2022.
• On February 26, 2025, he acquired 38,599 shares of common stock in the form of RSUs, which vest 25% on March 1, 2026, and annually thereafter.
• Also on February 26, 2025, Blackford sold 22,252 shares at $112.13 per share to cover tax obligations related to the vesting of the performance RSUs.
• Following these transactions, Blackford beneficially owns 216,886 shares of iRhythm Technologies common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are routine and related to compensation and tax obligations. The vesting of RSUs is a positive sign, but the sale of shares for tax purposes is a minor negative.

Positives

• The vesting of performance-based RSUs indicates that performance conditions set by the Compensation Committee were met.

Negatives

• The sale of shares to cover tax obligations, while common, can be perceived negatively as it reduces the executive's stake in the company.

Risks

• Future stock transactions by company executives could impact the stock price.

Future Outlook

The RSUs vest over time, contingent on continued service, suggesting a long-term commitment from the CEO.

Industry Context

Executive stock transactions are common and closely monitored by investors for insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• Executive compensation packages often include RSUs as a way to align management's interests with those of shareholders, similar to practices at companies like Medtronic and Boston Scientific.
• The vesting schedules for RSUs, such as the one described in the document, are typical in the industry and designed to incentivize long-term performance.

Stakeholder Impact

• Shareholders may view the vesting of RSUs as a positive sign of management performance.
• The sale of shares to cover tax obligations could have a minor negative impact on investor sentiment.

Key Dates